Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H. A. Verhoeven

Showing results (151-160 of 211) with videos related to

Pageof 22
Sort By:
European Journal of Endocrinology|May 4, 2013
Surgery for adrenocortical carcinoma in The Netherlands: analysis of the national cancer registry dataT M A Kerkhofs, R H A Verhoeven, H J Bonjer, et al.
Cancers|April 5, 2020
External Validation of the Dutch SOURCE Survival Prediction Model in Belgian Metastatic Oesophageal and Gastric Cancer PatientsJ J van Kleef, H G van den Boorn, R H A Verhoeven, et al.
The British Journal of Surgery|August 23, 2022
Population-based study of treatment and outcome of recurrent oesophageal or junctional cancerMarieke Pape, Pauline A J Vissers, David Bertwistle, et al.
European Journal of Cancer (Oxford, England : 1990)|March 15, 2020
A population-based study on intestinal and diffuse type adenocarcinoma of the oesophagus and stomach in the Netherlands between 1989 and 2015Rosa T van der Kaaij, Willem J Koemans, Margreet van Putten, et al.
International Journal of Radiation Oncology, Biology, Physics|May 24, 2023
Late Toxicity and Health-Related Quality of Life Following Definitive Chemoradiotherapy for Esophageal Cancer: A Systematic Review and Meta-analysisMarieke Pape, Linde M Veen, Thom M Smit, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|January 14, 2020
Increased assessment of HER2 in metastatic gastroesophageal cancer patients: a nationwide population-based cohort studyWillemieke P M Dijksterhuis, Rob H A Verhoeven, Sybren L Meijer, et al.
Cancer Epidemiology|January 23, 2021
Changes in hospital variation in the probability of receiving treatment with curative intent for esophageal and gastric cancerJosianne C H B M Luijten, Pauline A J Vissers, Hester Lingsma, et al.
Inflammatory Bowel Diseases|September 28, 2019
Laryngeal Carcinoma in Patients With Inflammatory Bowel Disease: Clinical Outcomes and Risk FactorsSteffi E M van de Ven, Lauranne A A P Derikx, Iris D Nagtegaal, et al.
Journal of Thoracic Disease|April 16, 2026
The impact of best practice meetings on clinical outcomes in surgical and oncological care: a scoping reviewJanne van den Hurk, Felix Hers, Lars van de Sanden, et al.
Journal of Gastroenterology|July 31, 2023
The impact of the COVID-19 pandemic on the diagnosis, stage, and treatment of esophagogastric cancerBenthe H Doeve, Jeanne A C Bakx, Peter D Siersema, et al.
Pageof 22

Showing results (151-160 of 211) with videos related to

Sort By:
Pageof 22
European Journal of Endocrinology|May 4, 2013
Surgery for adrenocortical carcinoma in The Netherlands: analysis of the national cancer registry dataT M A Kerkhofs, R H A Verhoeven, H J Bonjer, et al.
Cancers|April 5, 2020
External Validation of the Dutch SOURCE Survival Prediction Model in Belgian Metastatic Oesophageal and Gastric Cancer PatientsJ J van Kleef, H G van den Boorn, R H A Verhoeven, et al.
The British Journal of Surgery|August 23, 2022
Population-based study of treatment and outcome of recurrent oesophageal or junctional cancerMarieke Pape, Pauline A J Vissers, David Bertwistle, et al.
European Journal of Cancer (Oxford, England : 1990)|March 15, 2020
A population-based study on intestinal and diffuse type adenocarcinoma of the oesophagus and stomach in the Netherlands between 1989 and 2015Rosa T van der Kaaij, Willem J Koemans, Margreet van Putten, et al.
International Journal of Radiation Oncology, Biology, Physics|May 24, 2023
Late Toxicity and Health-Related Quality of Life Following Definitive Chemoradiotherapy for Esophageal Cancer: A Systematic Review and Meta-analysisMarieke Pape, Linde M Veen, Thom M Smit, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|January 14, 2020
Increased assessment of HER2 in metastatic gastroesophageal cancer patients: a nationwide population-based cohort studyWillemieke P M Dijksterhuis, Rob H A Verhoeven, Sybren L Meijer, et al.
Cancer Epidemiology|January 23, 2021
Changes in hospital variation in the probability of receiving treatment with curative intent for esophageal and gastric cancerJosianne C H B M Luijten, Pauline A J Vissers, Hester Lingsma, et al.
Inflammatory Bowel Diseases|September 28, 2019
Laryngeal Carcinoma in Patients With Inflammatory Bowel Disease: Clinical Outcomes and Risk FactorsSteffi E M van de Ven, Lauranne A A P Derikx, Iris D Nagtegaal, et al.
Journal of Thoracic Disease|April 16, 2026
The impact of best practice meetings on clinical outcomes in surgical and oncological care: a scoping reviewJanne van den Hurk, Felix Hers, Lars van de Sanden, et al.
Journal of Gastroenterology|July 31, 2023
The impact of the COVID-19 pandemic on the diagnosis, stage, and treatment of esophagogastric cancerBenthe H Doeve, Jeanne A C Bakx, Peter D Siersema, et al.
Pageof 22